{
    "clinical_study": {
        "@rank": "72162", 
        "arm_group": [
            {
                "arm_group_label": "DM, angio group", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "DM, OCT group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "non DM, angio group", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "non DM, OCT group", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "Optical coherence tomography (OCT) after the stent procedure to improve the adhesion and\n      expansion, or incomplete uncovered struts attached to the main track. OCT in clinical areas\n      by improving the parameters of the best stent will be useful. However, for better results\n      for optical coherence tomography in percutaneous interventions have little useful data on\n      the role. Randomized controlled study of the traditional percutaneous coronary intervention\n      and intervention using optical coherence tomography."
        }, 
        "brief_title": "Randomized Controlled Study of the Traditional Percutaneous Coronary Intervention and Intervention Using Optical Coherence Tomography of Incomplete Stent Adhesion and Extent of the Formation of Neointima by Resolute Zotarolimus-eluting Stent Insertion", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Coronary Artery Disease", 
            "Stable Angina", 
            "Unstable Angina"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Angina Pectoris", 
                "Angina, Unstable", 
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Single lesion in a Single vessel\n\n          -  Reference vessel diameter 2.5 - 3.5 mm\n\n          -  Lesion length \u2264 34 mm and \u2264 34 mm stent length\n\n          -  Stable angina requiring revascularization, patients with unstable angina\n\n          -  The patient has no difficulty to enforce the follow-up angiography\n\n          -  Patient is \u2265 20 years old\n\n        Exclusion Criteria:\n\n          -  Lesions with graft vessel, thrombosis, restenosis, and bifurcation requiring 2 stents\n\n          -  Reference vessel diameter < 2.5 mm or > 4.0mm\n\n          -  Contraindication to anti-platelet agents\n\n          -  Treated with any DES within 3 months at other vessel\n\n          -  Creatinine level \u2265 2.0 mg/dL or ESRD\n\n          -  Severe hepatic dysfunction (3 times normal reference values)\n\n          -  Patients with LVEF < 30%\n\n          -  Life expectancy 1 year\n\n          -  Lesions with CTO or left main\n\n          -  Target vessel of ST-elevation MI\n\n          -  Lesions requiring overlapped stenting or more than 2 DES in each vessel\n\n          -  Heavy calcified lesions (definite calcified lesions on angiogram)\n\n          -  Far distal or tortuous lesions having difficulties in OCT evaluation or follow-up OCT\n\n          -  Pregnant women or women with potential childbearing"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "115", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01869842", 
            "org_study_id": "1-2011-0070"
        }, 
        "intervention": [
            {
                "arm_group_label": "DM, angio group", 
                "description": "the traditional percutaneous coronary intervention by Resolute zotarolimus-eluting stent insertion", 
                "intervention_name": "percutaneous coronary intervention", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "DM, OCT group", 
                "description": "the percutaneous coronary intervention using optical coherence tomography by Resolute zotarolimus-eluting stent insertion", 
                "intervention_name": "OCT-guided percutaneous coronary intervention", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "non DM, angio group", 
                "description": "the traditional percutaneous coronary intervention by Resolute zotarolimus-eluting stent insertion", 
                "intervention_name": "percutaneous coronary intervention", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "non DM, OCT group", 
                "description": "the percutaneous coronary intervention using optical coherence tomography by Resolute zotarolimus-eluting stent insertion", 
                "intervention_name": "OCT-guided percutaneous coronary intervention", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Resolute zotarolumus-eluting stent", 
            "optical coherence tomography"
        ], 
        "lastchanged_date": "June 4, 2013", 
        "location": {
            "contact": {
                "email": "mkhong61@yuhs.ac", 
                "last_name": "MyeongKi Hong, MD, PhD", 
                "phone": "82-2-2228-8460"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Severance Hospital"
            }, 
            "investigator": {
                "last_name": "Myeong Ki Hong, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "overall_contact": {
            "email": "mkhong61@yuhs.ac", 
            "last_name": "Myeong Ki Hong, Md, PhD", 
            "phone": "82-2-2228-8460"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "ratio of the stent strut", 
            "safety_issue": "No", 
            "time_frame": "Angiographic follow-up with OCT at 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01869842"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}